Kentaro Shimura
Overview
Explore the profile of Kentaro Shimura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
70
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hiramatsu K, Ueda Y, Yagi A, Morimoto A, Egawa-Takata T, Nakagawa S, et al.
Hum Vaccin Immunother
. 2021 Nov;
18(1):1951098.
PMID: 34802371
Human papillomavirus (HPV) vaccine has been used to prevent chronic HPV infection, which accounts for cervical cancer. Japanese Ministry of Health, Labor and Welfare (MHLW) conducted an HPV vaccination campaign...
2.
Kakubari R, Egawa-Takata T, Ueda Y, Tanaka Y, Yagi A, Morimoto A, et al.
Hum Vaccin Immunother
. 2020 Jul;
17(2):434-442.
PMID: 32730107
Introduction: In Japan, two groups of women, HPV vaccinated and unvaccinated, are approaching age 20, when they should begin cervical cancer screening. To improve Japan's current poor cervical cancer screening...
3.
Shiomi M, Ueda Y, Abe H, Yagi A, Sakiyama K, Kimura T, et al.
Hum Vaccin Immunother
. 2020 Apr;
16(10):2555-2558.
PMID: 32243236
: In June of 2013, Japan's Ministry of Health, Labor and Welfare (MHLW) suspended its position of strong recommendation for the routine immunization of young girls against the Human Papilloma...
4.
Yagi A, Ueda Y, Tanaka Y, Nakae R, Kakubari R, Morimoto A, et al.
Hum Vaccin Immunother
. 2018 Jun;
14(10):2497-2502.
PMID: 29883254
In Japan, the trend for cervical cancer at younger ages has been increasing. As a countermeasure, the HPV vaccine was introduced as a routine vaccination in April 2013. However, the...
5.
Egawa-Takata T, Ueda Y, Morimoto A, Tanaka Y, Yagi A, Terai Y, et al.
J Epidemiol
. 2017 Nov;
28(3):156-160.
PMID: 29129894
Background: In Japan, the rate of cervical cancer screening is remarkably low, especially among women in their twenties and thirties, when cervical cancer is now increasing dramatically. The aim of...
6.
Yagi A, Ueda Y, Egawa-Takata T, Tanaka Y, Nakae R, Morimoto A, et al.
Hum Vaccin Immunother
. 2017 Mar;
13(7):1700-1704.
PMID: 28272968
Objective: In Japan, the possible adverse events upon HPV vaccination was widely reported in the media. MHLW announced the suspension of aggressively encouraging HPV vaccination in 2013, and inoculation rate...
7.
Yagi A, Ueda Y, Egawa-Takata T, Tanaka Y, Morimoto A, Terai Y, et al.
BMC Public Health
. 2016 Sep;
16(1):1013.
PMID: 27663658
Background: In Japan, new HPV immunizations have dropped dramatically after repeated adverse media reports and a June 2013 temporary suspension of the government's recommendation for the vaccine. The aim of...
8.
Yagi A, Ueda Y, Egawa-Takata T, Tanaka Y, Terai Y, Ohmichi M, et al.
J Obstet Gynaecol Res
. 2016 Sep;
42(12):1802-1807.
PMID: 27641631
Aim: In Japan, the rate of routine cervical cancer screening is quite low, and the incidence of cervical cancer has recently been increasing. Our objective was to investigate ways to...
9.
Egawa-Takata T, Ueda Y, Tanaka Y, Morimoto A, Kubota S, Yagi A, et al.
Int J Clin Oncol
. 2016 Mar;
21(5):962-968.
PMID: 26968588
Background: Cervical cancer and its precancerous lesions caused by human papilloma virus (HPV) are steadily increasing in women in Japan. In comparison with women in other resource-rich countries, young women...